Page last updated: 2024-11-05

2,4-thiazolidinedione and Colorectal Neoplasms

2,4-thiazolidinedione has been researched along with Colorectal Neoplasms in 1 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
" We have investigated the therapeutic properties of 5-[[6-[(2-fluorophenyl)-methoxy]-2-napthalenyl]-methyl]-2,4-thiazolidinedione (MCC-555) a PPARgamma agonist in human colorectal cancer cells."3.76MCC-555-induced NAG-1 expression is mediated in part by KLF4. ( Baek, SJ; Cekanova, M; Lee, SH; McEntee, MF, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cekanova, M1
Lee, SH1
McEntee, MF1
Baek, SJ1

Other Studies

1 other study available for 2,4-thiazolidinedione and Colorectal Neoplasms

ArticleYear
MCC-555-induced NAG-1 expression is mediated in part by KLF4.
    European journal of pharmacology, 2010, Jul-10, Volume: 637, Issue:1-3

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression R

2010